Skip to main content
. 2014 Aug 7;20(29):10151–10157. doi: 10.3748/wjg.v20.i29.10151

Table 3.

Incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasaemia (n = 665)

Group of patients ERCP (n) Pancreatitis (n) Pancreatitis Hyperamylasaemia (n) Hyperamylasaemia
Indomethacin 347 20 (mild: 16, severe: 4) 5.76% 81 23.34%
Control 318 22 (mild: 18, severe: 4) 6.92% 79 24.84%
Total 665 42 6.32% 160 24.06%

There were no statistically significant differences (P = 0.541 and P = 0.651). ERCP: Endoscopic retrograde cholangiopancreatography.